TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI ® (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and Research in ...
Allergic diseases represent a major global health burden, placing significant strain on health care systems worldwide. Severe ...
ABSTRACT: Influenza A viruses initiate infection when the envelope glycoprotein hemagglutinin (HA) binds sialic‑acid-containing receptors on host cells and mediates membrane fusion. HA‑mediated ...
Autoimmune disorders occur when the body’s immune system cannot differentiate between cells that are its own and pathogens. Consequently, the body’s immune system attacks itself causing inflammation ...
aDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA bCenter for Vaccine Research and Pandemic Preparedness, Icahn School of Medicine at Mount Sinai, New York, NY, ...
Bispecific antibodies offer dual targeting, enhancing specificity and therapeutic efficiency while reducing toxicity compared to traditional monoclonal antibodies. Fragment-based, symmetric, and ...
Introduction: Human papillomavirus (HPV) infection represents a significant public health concern due to its strong association with various cancers and other diseases. The development and ...
Amivantamab is a bispecific antibody targeting epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition factor, demonstrating efficacy in patients with non–small cell lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results